Evidence map›Paper›PMID 36811935›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2023

Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery.

Giuseppe Tarantini, Gilbert Tang, Luca Nai Fovino, Daniel Blackman, Nicolas M Van Mieghem, Won-Keun Kim, Nicole Karam, Pedro Carrilho-Ferreira, Stephane Fournier, Jerzy Pręgowski and 15 more

Open access · bronzeAbstract readConsensus Statement
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
30.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Article
  7. Emergency PCI for Right Coronary Artery STEMI and Cardiogenic Shock in a Patient With Prior TAVR.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Article
  13. Review
  14. Review
  15. Transcatheter aortic valve implantation: latest evidence, gaps in knowledge, and future directions.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2025
    Review
  16. Article
  17. Review
  18. Redo-TAVI with the ACURATE platform for failure of short-frame transcatheter heart valves.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 5 institutions in 11 countries.

Giuseppe TarantiniDepartment of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Gilbert TangDepartment of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA.
Luca Nai FovinoDepartment of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Daniel BlackmanLeeds Teaching Hospitals NHS Trust, University of Leeds, Leeds, UK.
Nicolas M Van MieghemThoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Won-Keun KimKerckhoff Heart Center, Bad Nauheim, Germany.
Nicole KaramDepartment of Cardiology, Hôpital Européen Georges-Pompidou, Paris, France.
Pedro Carrilho-FerreiraServiço de Cardiologia, Hospital de Santa Maria, CHULN, and Centro de Cardiologia da Universidade de Lisboa, Faculdade de Medicina de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.
Stephane FournierLausanne University Center Hospital, Lausanne, Switzerland.
Jerzy PręgowskiNational Institute of Cardiology, Warsaw, Poland.
Chiara FraccaroDepartment of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Flavien VincentDivision of Cardiology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Rui Campante TelesHospital de Santa Cruz, CEDOC, Nova Medical School, Lisbon, Portugal.
Darren MylotteDepartment of Cardiology, University Hospital Galway, Galway, Ireland.
Ivan WongDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Gintautas BieliauskasDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Martin CzernyUniversity Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.
Nikolaos BonarosDepartment of Cardiac Surgery, Medical University of Innsbruck, Innsbruck, Austria.
Alessandro ParolariDepartment of Biomedical Sciences for Health, University of Milano, Milan, Italy and University Cardiac Surgery, Policlinico San Donato IRCCS, Milan, Italy.
Darius DudekInstitute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Didier TchetcheClinique Pasteur, Toulouse, France.
Hélène EltchaninoffDepartment of Cardiology, CHU Rouen, France.
Ole de BackerDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Giulio StefaniniDepartment of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research Hospital, Rozzano-Milan, Italy.
Lars SondergaardDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Universitäts-Herzzentrum Freiburg-Bad Krozingen · DEUniversity of Padua · ITClinique Pasteur · FRHôpital Européen Georges-Pompidou · FRRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment. Moreover, it also focuses on commissural alignment of transcatheter heart valves and coronary re-access after TAVI and redo-TAVI.

Indexed as

Aortic Valve StenosisCardiologyCoronary Artery DiseasePercutaneous Coronary InterventionTranscatheter Aortic Valve ReplacementAortic ValveHumansTreatment Outcome

Identifiers

PMID36811935
PMCPMC10174192
OpenAlexW4321612395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.